• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Quipt Home Medical Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Other Events, Financial Statements and Exhibits

    3/16/26 7:41:06 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care
    Get the next $QIPT alert in real time by email
    false 0001540013 00-0000000 0001540013 2026-03-13 2026-03-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of

    The Securities Exchange Act of 1934

     

    March 13, 2026

    Date of Report (Date of earliest event reported)

     

     

    Quipt Home Medical Corp.

    (Exact name of registrant as specified in its charter)

     

     

    British Columbia, Canada

    (State or other jurisdiction of incorporation)

     

    001-40413   N/A
    (Commission File Number) (IRS Employer Identification No.)

     

    1019 Town Drive  
    Wilder, Kentucky ​ 41076 
    (Address of principal executive offices) ​ (Zip Code)

     

    (859) 878-2220

    (Registrant’s telephone number, including area code)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Shares, without Par Value ​ QIPT ​ The Nasdaq Capital Market
            Toronto Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    INTRODUCTORY NOTE

     

    On March 16, 2026 (the “Closing Date”), Quipt Home Medical Corp., a corporation existing under the laws of British Columbia (“Quipt”), announced the closing of its previously announced transaction with 1567208 B.C. Ltd., a company incorporated under the laws of British Columbia (the “Purchaser”), and REM Aggregator, LLC, a Delaware limited liability company (“Parent”), pursuant to the previously announced arrangement agreement dated December 14, 2025 (the “Arrangement Agreement”), by and among Quipt, the Purchaser and Parent. Pursuant to the terms of the Arrangement Agreement, among other things, the Purchaser acquired all of the issued and outstanding common shares (collectively, the “Shares”) of Quipt on the Closing Date for US$3.65 per Share in cash (the “Consideration”), by way of a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”).

     

    Item 1.01

     

    The information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated by reference into this Item 1.01.

     

    Parent obtained incremental debt financing for the purpose of facilitating the transactions contemplated by the Arrangement Agreement. On March 13, 2026, Parent entered into an amendment to that certain amended and restated credit and guaranty agreement, initially dated as of September 16, 2022 (as amended, restated, increased, extended, supplemented or otherwise modified from time to time, by and among, Parent, REM Borrower, LLC, a Delaware limited liability company, as the borrower, and Quipt, as a guarantor, and the other persons party thereto from time to time as loan parties, the lenders party thereto from time to time and First-Citizens Bank & Trust Company, as administrative agent, which provides for incremental revolving loan capacity.

     

    Item 2.01. Completion of Acquisition or Disposition of Assets.

     

    In connection with the Arrangement, at 12:01 a.m. (Vancouver Time) (the “Effective Time”) on the Closing Date, Purchaser acquired all of the issued and outstanding Shares of Quipt and Quipt became a wholly owned indirect subsidiary of Parent.

     

    At the Effective Time, (i) each Share outstanding immediately prior to the Effective Time, other than Shares held by a dissenting holder of Shares who has validly exercised such holder’s dissent rights, was deemed to be assigned and transferred by the holder thereof to the Purchaser in exchange for the Consideration for each Share held; (ii) each option to purchase Shares (an “Option”) outstanding immediately prior to the Effective Time, whether vested or unvested, was deemed to be unconditionally vested and exercisable and such Options were deemed to be surrendered and transferred to Quipt in exchange for a cash payment by or on behalf of Quipt in respect of each Share subject to each Option equal to the amount (if any) by which the Consideration exceeded the exercise price of such Option, subject to applicable tax withholdings, and such Option was cancelled immediately after its transfer; and (iii) each restricted share unit (an “RSU”) outstanding immediately prior to the Effective Time, whether vested or unvested, was deemed to be transferred to Quipt in exchange for the Consideration for such RSU, subject to applicable tax withholdings, and such RSU was cancelled immediately after its transfer. The aggregate consideration payable by the Purchaser to acquire the Shares, Options and RSUs outstanding immediately prior to the Effective Time is approximately $173 million.

     

    The foregoing description of the Arrangement Agreement and the Arrangement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Arrangement Agreement, a copy of which is attached as Exhibit 2.1 to Quipt’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on December 15, 2025, the terms of which are incorporated herein by reference.

     

    The information contained in the Introductory Note and Items 3.01, 3.03, 5.01, 5.02 and 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01.

     

     

     

     

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    Quipt notified the Nasdaq Stock Market (“NASDAQ”) that, as of the Effective Time, each Share issued and outstanding immediately prior to such time was acquired by the Purchaser. On the Closing Date, in connection with the completion of the Arrangement, Quipt requested NASDAQ to promptly file with the SEC a Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on Form 25 to delist the Shares from the NASDAQ and deregister the Shares under Section 12(b) of the Exchange Act. Upon effectiveness of such Form 25, Quipt intends to file with the SEC a Certification and Notice of Termination on Form 15 to terminate the registration of the Company’s Shares under Section 12(g) the Exchange Act and request that Quipt’s reporting obligations under Sections 13 and 15(d) of the Exchange Act be suspended.

     

    On the Closing Date, Quipt also notified the Toronto Stock Exchange (“TSX”) that the Arrangement had been completed. The Shares are expected to be delisted from the TSX on or about March 17, 2026. Quipt intends to promptly apply to cease to be a reporting issuer in each province and territory of Canada.

     

    Trading of the Shares on the NASDAQ was halted prior to the opening of trading on the Closing Date. The Shares will cease trading on the TSX at the close of business on March 17, 2026.

     

    The information set forth in the Introductory Note and Items 2.01 and 3.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01.

     

    Item 3.03. Material Modification to Rights of Security Holders.

     

    On March 16, 2026, in connection with the completion of the Arrangement, each Share that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive the Consideration at the Effective Time.

     

    The information contained in the Introductory Note and Items 2.01, 3.01 and 5.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.

     

    Item 5.01. Changes in Control of Registrant.

     

    In connection with the Arrangement, a change of control of Quipt occurred and Quipt became a wholly owned indirect subsidiary of Parent.

     

    The information contained in the Introductory Note and Items 2.01, 3.01, 3.03 and 5.02 of this Current Report on Form 8-K is incorporated by reference into this Item 5.01.

     

    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    In connection with the completion of the Arrangement and in accordance with the Arrangement Agreement, effective as of the Effective Time, Mark Greenberg, Kevin Carter, and Brian Wessel resigned from Quipt’s board of directors (the “Board”) and any committees thereof, and the following persons were appointed to the Board: Stephen Griggs; Michael Niegsch; and Johnny Wilhelm. Gregory Crawford, Quipt’s Chief Executive Officer and a member of the Board prior to completion of the Arrangement, remains on the Board. Additionally, in accordance with the Arrangement Agreement and effective as of the Effective Time, Hardik Mehta (Chief Financial Officer and Principal Financial Officer) and Thomas Roehrig (Chief Accounting Officer and Principal Accounting Officer) resigned as officers of Quipt. Following the Effective Time, each of Hardik Mehta and Thomas Roehrig were reappointed as Quipt’s Chief Financial Officer and Chief Accounting Officer, respectively, and Stephen Griggs was appointed as Executive Chairman of Quipt. Gregory Crawford will continue to serve as Quipt’s Chief Executive Officer.

     

    The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02.

     

     

     

     

    Item 8.01. Other Events.

     

    Incorporated by reference is Exhibit 99.1 attached hereto, a press release issued by Quipt on March 16, 2026 announcing the completion of the Arrangement.

     

      Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits:

     

    Exhibit Number   Description
    2.1†   Arrangement Agreement, dated as of December 14, 2025, between Quipt Home Medical Corp., a British Columbia corporation, 1567208 B.C. LTD, a company existing under the laws of British Columbia and REM Aggregator, LLC, a Delaware company (incorporated by reference to Exhibit 2.1 to Quipt’s Current Report on Form 8-K filed on December 15, 2025)
    99.1   Press release issued by Quipt Home Medical Corp. on March 16, 2026
    104  

    Cover Page Interactive Data File (formatted as Inline XBRL and embedded within the Inline XBRL document)

     

    † Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      Quipt Home Medical Corp.
       
    Date: March 16, 2026 By: /s/ Hardik Mehta
        Hardik Mehta
        Chief Financial Officer

     

     

    Get the next $QIPT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QIPT

    DatePrice TargetRatingAnalyst
    5/14/2025$1.70Buy → Hold
    Canaccord Genuity
    5/17/2024Mkt Perform → Underperform
    Raymond James
    2/16/2024Outperform → Mkt Perform
    Raymond James
    6/14/2023$11.00Buy
    Canaccord Genuity
    10/20/2021$7.50Buy
    The Benchmark Company
    10/20/2021$7.50Buy
    Benchmark
    More analyst ratings

    $QIPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager

    CINCINNATI, March 16, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company" or "Quipt") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the successful completion of the previously-announced plan of arrangement under the provisions of the Business Corporations Act (British Columbia) (the "Arrangement") in accordance with an arrangement agreement (the "Arrangement Agreement") dated December 14, 2025 among the Company, 1567208 B.C. Ltd. (the "Purchaser") and REM Aggregator, LLC. Pursuant to the Arrangement, and in accordance with the terms of the Arrangement Agreement, the Purchaser, which inclu

    3/16/26 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Receives Final Order Approving Arrangement

    CINCINNATI, March 05, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, announces that the Supreme Court of British Columbia issued a final order today in connection with the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement") pursuant to which affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC will acquire all of the issued and outstanding common shares of the Company (each, a "Share") for cash consideration of US$3.65 per Share. The final order was the final substan

    3/5/26 8:30:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders

    CINCINNATI, March 03, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its special meeting of holders (the "Shareholders") of common shares (the "Shares") of the Company held on March 3, 2026 (the "Meeting") in Sarasota, Florida. The Shareholders voted to approve the special resolution (the "Arrangement Resolution") approving the plan of arrangement under the Business Corporations Act (British Columbia), involving, among other things, the acquisition by affiliates of Kingswood Capital Management, L.P. and Forager Capital Ma

    3/3/26 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quipt Home Medical downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Quipt Home Medical from Buy to Hold and set a new price target of $1.70

    5/14/25 8:58:24 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform

    5/17/24 7:45:25 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform

    2/16/24 8:29:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wessel Brian Joseph returned $787,411 worth of shares to the company (215,729 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:46:40 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Accounting Officer Roehrig Thomas returned $631,450 worth of shares to the company (173,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:45:41 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Compliance Officer Miles Mark Alan returned $401,500 worth of shares to the company (110,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:45:08 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Exec VP Operations Gamble Patrick Dennis bought $41,634 worth of shares (17,000 units at $2.45), increasing direct ownership by 74% to 40,057 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    12/30/24 4:05:11 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.

    SCHEDULE 13D/A - Quipt Home Medical Corp. (0001540013) (Subject)

    3/16/26 1:46:50 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form S-8 POS filed by Quipt Home Medical Corp.

    S-8 POS - Quipt Home Medical Corp. (0001540013) (Filer)

    3/16/26 9:27:04 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form S-8 POS filed by Quipt Home Medical Corp.

    S-8 POS - Quipt Home Medical Corp. (0001540013) (Filer)

    3/16/26 9:26:27 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Financials

    Live finance-specific insights

    View All

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager's $3.10 per share proposal, and a 54% premium to Quipt's 30-day VWAP as of December 12, 2025 CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has entered into a definitive agreement (the "Arrangement Agree

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

    Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal third quarter 2025 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, August 12, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-85

    8/11/25 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025

    CINCINNATI, July 29, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Third quarter 2025 financial results on Monday, August 11, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, August 12, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are:  Canada/US Toll Free:1 (833) 752 3722 International:1 (647) 846 8549    A live webcast of the call will be accessible via the investor

    7/29/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Quipt Home Medical Corp.

    SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:07:36 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:09 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Leadership Updates

    Live Leadership Updates

    View All

    Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting

    CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce its strategic priorities for calendar 2025 and the voting results from its annual general meeting of shareholders held on March 17, 2025 (the "Meeting") in Sarasota, Florida. The total number of shares represented in person or by proxy at the Meeting was 31,400,043, representing 72.87% of the total issued and outstanding shares in the capital of the Company. As it relates to its strategic priorities for 2025, the Company remains committed to returning to hist

    3/24/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

    CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme

    3/28/24 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces New Independent Board Member

    CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio

    2/3/22 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care